Nuwacell Biotechnologies Co., Ltd.
PrivateLast Round
Series A
Sep 13, 2022
Company Overview
Nuwacell Biotechnologies Co., Ltd. operates in Healthcare & Life Sciences and is based in Hefei. Its latest recorded funding round was a Series A round in September 2022.
Nuwacell Biotechnologies Co., Ltd. is a biotechnology company that develops widely accessible iPSC-derived cell therapy products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nuwacell Biotechnologies Co., Ltd. Comparables
Compare Nuwacell Biotechnologies Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HebeCell | 85% | |
| iRegene Therapeutics | 83% | |
| CellOrigin Biotech | 81% |
For institutional investors. Book with your work email.
Nuwacell Biotechnologies Co., Ltd. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Nuwacell Biotechnologies Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| China Merchants Group | Series A |
| Legend Capital | Series A |
| GF Venture Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2022
Led by China Merchants Group and Legend Capital
For institutional investors. Book with your work email.
Nuwacell Biotechnologies Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nuwacell Biotechnologies Co., Ltd.'s valuation, stock price, and market status.
Is Nuwacell Biotechnologies Co., Ltd. a public or private company?
Nuwacell Biotechnologies Co., Ltd. is a private company.
What is the current stock price of Nuwacell Biotechnologies Co., Ltd.?
Nuwacell Biotechnologies Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Nuwacell Biotechnologies Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nuwacell Biotechnologies Co., Ltd. worth (valuation)?
Valuation information for Nuwacell Biotechnologies Co., Ltd. is not publicly available.
Can I buy Nuwacell Biotechnologies Co., Ltd. stock?
Nuwacell Biotechnologies Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nuwacell Biotechnologies Co., Ltd.'s last funding round?
Nuwacell Biotechnologies Co., Ltd.'s most recent funding round was Series A on September 13, 2022.
Who are the main investors in Nuwacell Biotechnologies Co., Ltd.?
Key investors in Nuwacell Biotechnologies Co., Ltd. include China Merchants Group, Legend Capital.
Will Nuwacell Biotechnologies Co., Ltd. IPO soon?
No public IPO plans have been announced for Nuwacell Biotechnologies Co., Ltd..
How can I track Nuwacell Biotechnologies Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Nuwacell Biotechnologies Co., Ltd.'s shares on secondary markets.